Supernus Pharmaceuticals - 株価

SUPN

25.51

毎日の変更:

1.45%

毎年:

60.04%

価格 日 年
Eisai 7,328.00 80.00 1.10% -8.70%
Abbott 115.63 -1.62 -1.38% 50.13%
Aurora Cannabis Inc 12.16 0.01 0.08% -21.45%
Adamas Pharmaceuticals 4.83 0.09 1.90% 44.18%
Aerie Pharmaceuticals 19.42 0.67 3.57% 33.93%
ANI Pharmaceuticals 30.34 0.84 2.85% -24.47%
Aphria Inc 20.46 0.62 3.13% 305.95%
Antares Pharma 4.01 -0.14 -3.37% 29.35%
Bristol-Myers Squibb 60.45 0.02 0.03% 4.84%
Cara Therapeutics 18.11 0.02 0.11% 31.14%
Corcept Therapeutics 23.75 -0.80 -3.26% 120.11%
Endo International Ordinary Shares 7.67 0.68 9.73% 110.14%
GW Pharmaceuticals 214.72 -0.22 -0.10% 146.21%
Horizon Pharma 86.77 -1.88 -2.12% 169.30%
Jazz Pharmaceuticals 161.41 -3.34 -2.03% 45.88%
Lannett 6.35 0.18 2.92% -15.67%
Eli Lilly 207.03 0.11 0.05% 52.54%
Marinus Pharmaceuticals 16.72 0.18 1.09% 740.20%
Pacira 70.57 1.37 1.98% 91.92%
Pfizer 34.35 -0.04 -0.12% 1.75%
Perrigo 41.82 0.78 1.90% -14.46%
Revance Therapeutics 24.03 -2.26 -8.60% 31.10%
Supernus Pharmaceuticals 25.51 0.37 1.45% 60.04%
Teva Pharmaceutical Industries 10.69 0.17 1.62% 20.59%
United Therapeutics 160.09 -4.25 -2.59% 75.36%
Canopy Growth Corp 39.16 -0.29 -0.74% 116.95%
Xeris Pharmaceuticals Inc 4.72 -0.12 -2.48% 143.30%

価格 日 年
NASDAQ 12609 -310.99 -2.41% 58.59%
Russell 2000 2202 10.77 0.49% 67.73%

SUPN:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
収益へのPE価格
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者